Objectives: There is a known relationship between abdominal aortic aneurysms (AAA) and thoracic aortic aneurysms (TAAs), but the exact prevalence has not been determined. This study quantifies the prevalence of TAAs in patients with known AAAs.
Objectives: As medical payment transitions to quality-and value-based incentives, increasing importance is placed on comparative metrics from administrative and clinical databases. This study compares the data and outcomes for open and endovascular abdominal aneurysm repair patients within Vizient (formerly University Health Consortium) and the Vascular Quality Initiative (VQI) with validation against detailed EMR data in academic clinical practice.
Methods: Vizient is based on International Classification of Diseases, 9th edition (ICD-9) procedure codes (38.34, 38.44, 38.64, 39.52, 39.71, 39.77, 39.78) whereas the VQI includes both Current Procedural Terminology and ICD-9 procedure codes (38.44, 39.71) and further exclusionary criteria are applied before reporting (mycotic aneurysms, suprarenal anastomoses, fenestrated grafts, and redo open repair). Institutional data was obtained through electronic medical record query of relevant ICD-9 codes, cross-check of reported VQI and Vizient procedures, and supplemented by retrospective chart review. Dates of inclusion were April 1, 2011 , to September 30, 2015 , to match available data and exclude post-ICD-10 reporting. Subsequent exclusions were performed by filtering Vizient data for relevant ICD-9 diagnosis criteria (441.3, 441.4). The VQI and Vizient datasets were compared across equivalent outcome variables.
Results: The Vizient query resulted in 335 cases while VQI resulted in 336. There were no significant differences between Vizient and VQI in patient age (71.71 6 9.85 vs 71.16 6 8.94; P ¼ .78), sex (22.09% vs 22.92% female; P ¼ .79), or ethnicity (0.6% vs 1.49% Hispanic/Latino; P ¼ .26). There were no significant differences in reported patient race for black (4.78% vs 4.46%; P ¼ .51), white (85.67% vs 90.18%; P ¼ .07), and Asian (0.3% vs 0.3%, P¼1.00). Reported primary insurer differed significantly between Vizient and VQI, including Medicare (78.81% vs 70.19%; P ¼ .01), Medicaid (3.58% vs 1.13%; P ¼ .0365), and commercial (9.55% vs 3.02%; P ¼ .0005). With outcomes measures, both total duration of stay (7.53 6 9.09 days vs 9.76 6 13.62 days; P ¼ .0064) and intensive care duration of stay (3.21 6 5.12 days vs 4.99 6 9.02 days; P ¼ .0008) were significantly longer in VQI. Percentage of surgeries performed in 2015 was significantly higher in VQI (9.25% vs 15.48%; P ¼ .01), although they did not differ significantly between 2011 and 2014. Rates of EVAR use were significantly higher in VQI (36.41% vs 45.83%; P ¼ .01) whereas open repair rates did not differ significantly (54.62% vs 54.17%; P ¼ .91). Inpatient mortality did not differ significantly between Vizient and VQI (3.58% vs 2.98%; P ¼ .505). Disposition to home (78.21% vs 76.49%; P ¼ .5949) and to inpatient hospital (1.79% vs 1.49%; P ¼ .7598) did not differ while disposition to rehabilitation (4.48% vs 17.56%, P < .0001) and to nursing home (11.94% vs 1.49%, P < .0001) did differ significantly between Vizient and VQI.
Conclusions: Our study reveals significant reporting differences of demographics and outcomes between a national administrative database (Vizient) and national clinical registry (VQI) when evaluating at the institutional level. Future studies will individually validate datasets against retrospectively collected institutional data and standardize outcomes measures within Vizient and VQI datasets to observe any correction in discrepancies in quality measures and outcomes. Methods: We studied all repairs of intact or symptomatic cAAA in the Vascular Quality Initiative between 2012 and 2017 without prior aortic surgeries. We defined cAAA as involving zone 6 or caudal for FEVAR, and a clamp above at least one renal artery for open repairs. Only FEVAR (off-the-shelf or custom-manufactured) or physician-modified endografts (PMEG) were included; we excluded branched grafts and chimney/snorkels. We used multilevel logistic regression to determine adjusted rates of perioperative death and acute kidney injury (>0.5 increase in creatinine), and Cox regression to compare long-term survival. For our primary analysis we grouped all endografts together, and as a secondary analysis we considered PMEG separately. As a secondary analysis, we calculated propensity scores for undergoing open versus FEVAR, and used them to construct inverse probability weights.
Results: There were 3361 cAAA repairs: 2123 open (63%), 1103 FEVAR (33%), and 135 PMEG (4%) with a median follow-up of 1.8 years. Patients undergoing FEVAR were more often older, male, with larger aneurysms, and higher rates of comorbidities including chronic obstructive pulmonary disease, coronary artery disease, chronic kidney disease, and congestive heart failure. The adjusted perioperative mortality for open and FEVAR was 5.2% and 2.6%, respectively (P ¼ .01). There was no difference in adjusted perioperative mortality between FEVAR and PMEG cases (2.6% vs 2.8%; P ¼ .87). Adjusted rates of acute kidney injury after open and FEVAR were 28% and 14% (P < .001), with no difference between FEVAR and PMEG (P ¼ .31). There was no difference in long-term survival based on repair type (open repair, hazard ratio, 1.04; 95% confidence interval, 0.7-1.5; P ¼ .83). There was no difference in long-term survival vbetween either open and PMEG or PMEG and FEVAR when PMEG was considered separately. In the propensityweighted analysis, there was no difference in survival based on repair type. Long-term mortality after PMEG in the propensity-weighted analysis was not statistically different than after open or fenestrated repair (Fig) .
Conclusions: In patients undergoing cAAA repair, open repair was associated with higher rates of adjusted perioperative mortality and renal dysfunction, but no difference in long-term survival. PMEG were associated with similar perioperative results as FEVAR, but durability may be limited.
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